Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

4bqj4buV4bql4bq1xKlxZeG7ueG7uTHhurPhu7NA4buXQXFs4bqzw6NSxJDhurXEqeG7lXThurXhu7Phu5Vt4buz4bq1auG6oHPhu5nhurVB4buVw4HGsMSp4bq14bu2bHJqbOG7ueG7l+G6pOG7l+G7t+G6tUHhu7d0c+G7meG6tWvhu5fhu4/DgeG6tUHhu7fhu53hurXhu4nDtXPhu5XhurXEqFQo4buWSi3huqXEkeG6oy/hu5XhuqXDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buUbGVq4bqzw6NA4buVxalz4buZ4bq14buJw6l04bq1xKnDg2XhurXEqOG7r+G6teG7tcOBZXPhurXhu7TDgeG6vXPhurVx4bqq4bq1QOG7leG6ssSp4bq14buz4buVw6xy4bq14bqk4bq54bq1SuG6rnjEqeG6teG7s+G7lcOscuG6tVLEkOG6tcOg4buSSkXhuqHhurVz4buZ4bq54bqo4bq14bqn4bqnL+G6pcOi4bq1xKnhu5V04bq14buJ4buX4buNQTnhurXEqeG7r+G6teG7tcOBZXPhurVz4bq54bqo4bq1a8Oq4bq1xKlo4buz4bq14buz4buVbeG7s+G6teG7ueG6tOG6tWrhuqJz4buZ4bq1QeG7lcOBxrDEqeG6teG7tmxyamzhu7nhu5fhuqThu5fhu7fhurXDoGp04bq1xKnFqXPhu5nhurVB4bqo4bq14buY4buXcWxlauG6teG7uMSp4buXbHPEqWzhu7nhurXhu7Phu5XDqUHhurVB4bu34buXw7Rz4bqh4bq1QeG7t3Rz4buZ4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6teG7icO1c+G7leG6teG6pOG7l8OycuG6tWvhuq53c+G7meG6teG7lcWp4bq14buVaOG7s+G6tcSoVCjhu5ZKLeG6pcSRYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buIdGrhuqjhurPDo+G6o+G7l3Lhu5nhurXEqXFl4bu54bu5MeG6s8SpcuG7uS3hu7Phu5V0QXThurPhurVB4buXQXFsMeG6s1LEkOG6tcSp4buVdOG6teG7s+G7lW3hu7PhurVq4bqgc+G7meG6tUHhu5XDgcawxKnhurXhu7Zscmps4bu54buX4bqk4buX4bu34bq1QeG7t3Rz4buZ4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6teG7icO1c+G7leG6tcSoVCjhu5ZKLeG6pcSR4bq14buV4bubc+G7leG6teG6vXPhu5XhurXhuqXhurPhurXhu7nhu7fEqTHhurMvL8SpYeG7iWV0QeG7lWVz4buV4buVdGVh4bqkcy/hu5dy4buZL2ps4bu5cEF04buzL3Ns4bqm4bu5L+G6p8Oi4bqp4bqnL+G6pWNjauG6q8OixJHhuqvDouG6q8SRQcSRxJFi4bqnceG6pWHhuqZs4buJ4buz4bqz4bq1ZXFBMeG6s1LEkOG6tcSp4buVdOG6teG7s+G7lW3hu7PhurVq4bqgc+G7meG6tUHhu5XDgcawxKnhurXhu7Zscmps4bu54buX4bqk4buX4bu34bq1QeG7t3Rz4buZ4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6teG7icO1c+G7leG6tcSoVCjhu5ZKLeG6pcSR4bqz4bq1amVBZS3hu7Phu5V0QXQtdOG7t+G7l+G7meG7l3NlcS3hu7nhu7fEqTHhurPhu5VBQeG7s+G7uTcvL8SpanPhu5dy4buZYeG6pOG7l2xBc2Vy4buzccOB4bu5YeG6pHMvQWLhuqfDoi/DgeG7s3F0ZWpsai/hu4l04buhdHBlL+G6p8Oi4bqnw6Jf4bqlw6Jf4bqn4bqtL+G7t2xyamzhu7nhu5fhuqThu5fhu7dh4buh4buzbOG7meG6s+G6tS/Do0Dhu5XDgcawxKnhurXhu7Zscmps4bu54buX4bqk4buX4bu3OeG6teG7ueG6vXPhurXhu7Phu5XDrHLhurXEqcODZeG6teG7mOG7l3FsZWrhurXhu7jEqeG7l2xzxKls4bu5YeG6tcOg4bq8c+G7lTfhurVF4buy4bqh4bqjL+G7s8Oj4bqj4buz4bq1xKlxZeG7ueG7uTHhurPhu7Phu4h0auG6qOG6s8OjQOG7lcWpc+G7meG6teG7icOpdOG6tcSpw4Nl4bq14buSSkXhurVzw7LDgeG6teG7t+G7p2HhurXhuqThu5fDtcSp4bq1xKlo4buz4bq14buz4buVbeG7s+G6tUHhu7fDsnPhurVr4bqueMSp4bq1a+G6rmXhurXhu7dl4bq1auG6smXhurVB4bu3w7Jz4bq14bqt4bq1QeG7leG6tOG6tXPhu5nhu5Xhu5fDtXLhurVz4buZ4buLw4HhurVz4buV4buXw7Jz4bq1xKl14bq1a8aw4buX4bq1xKnhu5XhurBz4buZOeG6tUHhu7d0c+G7meG6tWt14bq1xKl14bq1cuG7q0HhurVB4buV4bq04bq1c+G7meG7leG7l8O1cuG6tWp04bq1KOG7l8O1c+G6tT7hurVB4buN4bq14bu0w4HGsMSp4bq14buZ4buXZeG6tUHhurnhu5fhurVB4bu3eGHhuqMv4buzw6PhuqPhu7PhurXEqXFl4bu54bu5MeG6s+G7s+G7iHRq4bqo4bqzw6NA4buVbHThurVz4buZ4buV4buXw7Jz4bq1xKnhurDDgeG6tWvhuq54xKnhurXEqcWpc+G7meG6teG7icaw4bq1QeG7t8Oyc+G6tUDhurvhu7PhurXEqeG7lcah4bq14bqo4bq14buVw7nEqeG6tVNs4bqm4bq1THPhu5lxZXNq4bq14buV4bup4buX4bq1a2nDgeG6tUHhu5XDqXPhu5nhurVz4bq54bqoOeG6tXPhu5XDgnPhu5nhurXhu4nDtXPhu5XhurVz4buVZ3PhurVr4bqueMSp4bq1auG6oHPhu5nhurVB4buVw4HGsMSp4bq14bu2bHJqbOG7ueG7l+G6pOG7l+G7t+G6tcSpdeG6tUHGsMSp4bq1a+G7q+G6teG7leG7qeG7l+G6teG7s+G7leG6osSp4bq1QeG7t8OBc+G7meG6teG7ieG7m3Phu5XhurVz4buVZXPhu5XhurXhu5Xhu69z4bq14bqr4bq1LeG6tWPhurVz4buZ4bq54bqo4bq14bu5dOG6teG6pHbhu5fhurVz4buVw4Jz4buZ4bq14buJw7Vz4buV4bq1c+G7lWdz4bq1c+G7g3Phu5nhurVr4bqueMSp4bq1auG6oHPhu5nhurXhu5nhu5fhur3hurVq4bqueMSpYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buIdGrhuqjhurPDo1Phu5nhu5Xhu5fDsnPhurXEqeG6sMOB4bq1xKnEgnPhu5nhurXEqeG7lXThurVB4buVaOG6qOG6teG7tmxyamzhu7nhu5fhuqThu5fhu7fhurVx4bq5cuG6teG7meG7l+G6vXLhurVw4buV4bq94bq1c+G6v3Phu5nhurXhu4nDtXPhu5XhurVz4buVZ3PhurXhu7Phu5Xhur3hu5fhurVq4bqgc+G7meG6tWvhu41z4bq1QeG7t3jhurVB4buVeeG6tXThuqzhuqjhurXhuqThurnhurXEqXXhurVB4buVw7ThurVx4bq5cuG6teG7meG7l+G6vXLhurXEqeG6veG6tXPhu5nDgeG6qOG6tcSp4buv4bq1QeG6tOG6teG6pHRz4buZYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buIdGrhuqjhurPDo+G7mOG7l3FsZWrhurXhu7jEqeG7l2xzxKls4bu54bq1c+G7lWhz4bq1cuG6u3Phu5XhurVrZ+G6qOG6tXHhurnhurXhu7Phu5Xhuq7hu69z4buZ4bq14buz4buVw6nhu7PhurVr4buX4buPw4HhurVB4bu34bud4bq1xKhUKOG7lkot4bqlxJHhurVracOB4bq1QeG7l8Oyc+G6teG6pOG6ueG6tWrDgeG6qOG6tXPhu5VoQeG6tcSp4buVdOG6tUF24buX4bq1c2XhuqjhurVr4bqueMSp4bq1UsSQ4bq1xKnhu5Vo4buz4bq1c+G7lcOtc2HhurXEqMWpc+G7meG6tUHhuqjhurXhu4nhurnhuqjhurVB4bul4bq14buV4bqo4bq14bqkw7lz4buZ4bq1xKl14bq1QeG7lcO04bq1a8Op4buz4bq14bqwc+G7meG6tWvhuq54xKnhurVz4buVw4HhurXEqWnDgeG6tcSpw4Nl4bq1QeG7leG7jeG6teG7meG7l3bhu5fhurVrxrDhu5fhurXhuqR24buX4bq1cXThurvhu5fhurVB4buVw4HGsMSp4bq1c+G6ueG6qOG6tXPhu5ll4bqo4bq1QeG7t3Rz4buZ4bq1QeG7lcOpc+G7meG6teG6pcOiYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buIdGrhuqjhurPDo8So4buVw4PhurVB4budxKnhu5XhurVw4buXw7Jy4bq14buY4buXw6ly4bq1a8awxKnhurVr4buX4buPw4HhurXhu5Xhurlz4buV4bq1w6DEqExU4bqh4bq14buY4buXcWxlauG6teG7uMSp4buXbHPEqWzhu7k54bq1xalz4buZ4bq1SmVz4buXbHHhurVU4oCZSmXhuqjhurVw4buV4buFc+G7meG6tWvhu51z4buV4bq1xKnFqXPhu5nhurVB4bqo4bq1a2Vz4buZ4bq1xKl14bq14bu5ZnPhurVB4buVw4HGsMSp4bq1a8O04bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6tcSp4buVdOG6tXPhu5XDgnPhu5nhurXhu4nDtXPhu5XhurVz4buVZ3PhurVB4buVxqHEqeG7leG6teG7lXjhu7Nh4bqjL+G7s8Oj4bqj4buz4bq1xKlxZeG7ueG7uTHhurPhu7Phu4h0auG6qOG6s8Oj4buU4buXw7Vz4bq14buY4buXcWxlauG6tWtlc+G7meG6tUHGoXPhu5XhurVBdMOpc+G6teG6pHbhu5fhurXEqcOpxKnhurXEqcWpc+G7meG6tUHhuqjhurXhu4nhur104bq14buV4buXw7Ry4bq1QeG6ruG6tXPhu5Vnc+G6teG6pOG7j+G6tXLhurDEqeG6teG7s+G7lcah4bq14bqtYeG6peG6p8Oi4bq1I+G7uErhurXEqeG7lXThurVy4but4buX4bq14buJw7Vz4buV4bq1c+G7lWdz4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6teG6q+G6tXPhu5nhurnhuqhh4bq1xKjDqcSp4bq1c+G6rnbEqeG6teG7s+G7lcOpQeG6tUHhu7fhu5fDtHPhurXhuqThurnhurVz4buVw4Jz4buZ4bq1a+G7r3PhurXhuqThu53hurVyw4Fl4bq1QeG7t+G6ssSp4bq1QeG7l+G7jeG7s+G6tUHhu7d0c+G7meG6tcSo4buVxqFz4buV4bq14buz4buVw4PhurVSxJA54bq14buJZXThurXhu5nhu6ly4bq1xKnhur3hurXEqcOpxKnhurXhu4nDtXPhu5XhurXhuqThu5fDtXPhurXEqcODZeG6tcSp4bqyw4HhurXEqeG7leG7l+G7jXPhurXhu4nhu5dz4buVOeG6teG7ucOz4bq14buz4buV4bq94buX4bq1QeG7t+G6veG6teG6p2Hhuq3huqnDouG6tSPhu7hK4bq1xKnhu5V04bq1cuG7q0HhurVreEHhurVB4buVw4HGsMSp4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6tWrhurnhu5fhurXhuqvhurVz4buZ4bq54bqoYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buz4buIdGrhuqjhurPDo+G7tmxyamzhu7nhu5fhuqThu5fhu7fhurVx4bq54bq1cuG7q0HhurVB4bu3dHPhu5nhurVz4buVw4Jz4buZ4bq1cXThurvhu5fhurVB4buVw4HGsMSp4bq1a+G6rnjEqeG6teG7ueG6tOG6tWrhuqJz4buZ4bq1a+G7l+G7j8OB4bq1QeG7t+G7neG6tcSp4buVdOG6tUDhu7Fz4buZ4bq1QeG7lcawc+G7meG6tUp0c2VxauG6tUDhu7fDgXLhu7PhurVw4buV4buX4bq1xalz4buZ4bq14buJ4bud4bq1c+G7leG7l+G7kXLhurXEqFQo4buWSi3huqXEkWEvYeG6oy/hu7PDo+G6o+G7s+G6tcSpcWXhu7nhu7kx4bqz4buzRcOBQeG7lXThu7fhurPDo8OgQEA8KFMvKOG7l2xBc2VyK+G6oeG6oy/hu7PDow==

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Ấn Độ thử thành công rocket dẫn đường tầm xa, phê duyệt mua sắm quốc phòng trị giá hơn 8 tỷ USD

Ấn Độ thử thành công rocket dẫn đường tầm xa, phê duyệt mua sắm quốc phòng trị giá hơn 8 tỷ USD

Thế giới
(Baothanhhoa.vn) - Ấn Độ vừa thử nghiệm thành công lần đầu rocket dẫn đường tầm xa Pinaka, đồng thời phê duyệt gói mua sắm quốc phòng trị giá hơn 8 tỷ USD, cho thấy nỗ lực mạnh mẽ của nước này trong việc nâng cao năng lực tác chiến chính xác và hiện đại hóa lực lượng vũ trang.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh